Volume 55, Issue 10 pp. 2261-2269
Article

Design, Synthesis, Antifungal and Antibacterial Activities of N-phenyl and N-pyridinyl-5-(trifluoromethyl)-pyrazole-4-carboxamide Derivatives

Wenqing Yang

Wenqing Yang

State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals of Guizhou University, Guiyang, 550025 China

Search for more papers by this author
Xiang Zhou

Xiang Zhou

State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals of Guizhou University, Guiyang, 550025 China

Search for more papers by this author
Zhibing Wu

Corresponding Author

Zhibing Wu

State Key Laboratory Breeding Base of Green Pesticide and Agricultural Bioengineering, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Center for R&D of Fine Chemicals of Guizhou University, Guiyang, 550025 China

E-mail: [email protected]Search for more papers by this author
First published: 13 August 2018
Citations: 10

Abstract

A series of N-phenyl and N-pyridinyl-5-(trifluoromethyl)-pyrazole carboxamide derivatives (T1T25) were designed and synthesized. Bioassay results indicated that antifungal and antibacterial activities of title compounds could be obviously improved by placing trifluoromethyl on the 5-position of the pyrazole ring and substituted 4-pyridinyl at the amine side of the amide bond. The EC50 values of T3 against Gibberella zeae, Cytospora mandshurica, and Fusarium oxysporum were 14.7, 21.1, and 32.7 μg/mL, respectively, better than hymexazol (30.2, 47.3, and 42.5 μg/mL) and carboxin (34.2, >200, and >200 μg/mL). And the EC50 values of T6, T11, T12, T15, T18, T19, T23, and T25 against rice bacterial leaf blight were 17.0, 21.8, 21.9, 18.6, 16.8, 25.9, 9.4, and 24.4 μg/mL, respectively, much better than bismerthiazol (70.5 μg/mL).

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.